Analyst Reco. Sotera Health Company

Equities

SHC

US83601L1026

Real-time Estimate Cboe BZX Other stock markets 15:36:11 03/05/2024 BST			5-day change	1st Jan Change
11.16 ^USD	+2.34%		-1.84%	-33.59%

05-02	Sotera Health Shares Fall After Q1 Results, Outlook Reaffirmed	MT
05-02	Transcript : Sotera Health Company, Q1 2024 Earnings Call, May 02, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Upgrades Sotera Health to Buy From Neutral, Cuts Price Target to $16 From $18	04-03	MT
Sotera Health Shares Rise Following Jefferies Upgrade	03-25	MT
Jefferies Upgrades Sotera Health to Buy From Hold, Price Target is $15.50	03-25	MT
Barclays Adjusts Price Target on Sotera Health to $17 From $15, Maintains Overweight Rating	01-25	MT
RBC Cuts Price Target on Sotera Health to $20 From $22, Keeps Outperform Rating	11-02	MT
KeyBanc Adjusts Price Target on Sotera Health to $23 From $24, Maintains Overweight Rating	04/08/23	MT
RBC Raises Price Target on Sotera Health to $22 From $18, Keeps Outperform Rating	04/08/23	MT
Sotera Health Upgraded by KeyBanc to Overweight From Sector Weight Post Settlement of Ethylene Oxide Claims, Price Target Set at $24	26/06/23	MT
Barclays Adjusts Price Target on Sotera Health to $20 From $21, Maintains Overweight Rating	04/05/23	MT
RBC Cuts Price Target on Sotera Health to $18 From $19, Maintains Outperform Rating	04/05/23	MT
Barclays Adjusts Sotera Health Price Target to $21 From $22, Maintains Overweight Rating	04/04/23	MT
RBC Boosts Price Target on Sotera Health to $19 From $8, Maintains Outperform Rating	01/03/23	MT
JPMorgan Upgrades Sotera Health to Neutral From Underweight, Adjusts Price Target to $18 From $6	23/01/23	MT
Barclays Upgrades Sotera Health to Overweight From Underweight, Adjusts Price Target to $22 From $6	11/01/23	MT
Wolfe Research Upgrades Sotera Health to Outperform From Peer Perform, Price Target is $25	11/01/23	MT
Goldman Sachs Adjusts Sotera Health's Price Target to $8 From $9, Keeps Neutral Rating	23/11/22	MT
Barclays Downgrades Sotera Health Company to Underweight From Equalweight, Lowers Price Target to $6 From $7	15/11/22	MT
Barclays Trims Sotera Health Company's Price Target to $7 From $8, Maintains Equalweight Rating	03/11/22	MT
Citigroup Lowers Sotera Health Company's Price Target to $7 From $9, Maintains Neutral Rating	03/11/22	MT
Jefferies Lowers Sotera Health Company's Price Target to $7 From $21, Maintains Hold Rating	03/11/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Sotera Health Company

Equities

SHC

US83601L1026

Analyst Reco.

Filters